Our Clinical History

bioMérieux has an entrepreneurial spirit and many products, services and solutions for in vitro diagnostics are developed in-house. However, we are constantly open to acquiring new companies with interesting portfolios to either complement our existing ranges or explore new avenues of interest for our customers.

 

1963

Establishment of BD Mérieux

 

1974

Alain Mérieux takes control of BD Mérieux, which becomes bioMérieux

 

1986

Acquisition of Api Systems (La Balme, France), a specialist in bacterial identification systems

 

1988

Acquisition of Vitek®
(McDonnel Douglas, USA)

 

2001

Acquisition of OrganonTeknika (Akzo Nobel, Netherlands), a pioneering company working in HIV screening and viral load measurement

 

2004

bioMérieux is listed on the stock exchange

 

2006

Acquisition of Bacterial Barcodes (USA)

 

2007

Acquisition of Biomedics (Spain),
a specialist in culture media
Acquisition of BTF (Australia),
a specialist in industrial microbiology

 

2008

- Joint venture with Sysmex, the Japanese market leader in the field of in vitro diagnostics
- Joint venture with Shanghai Kehua
- Bio-engineering (China) for the production of microplate immunoassays
- Acquisition of AB BIODISK (Sweden)
- Acquisition of AviaraDx (USA), now bioTheranostics, a specialist in the molecular diagnosis of tumorous tissues
- Acquisition of PML Microbiologicals (USA), a company devoted to the development and production of culture media

 

2010

Acquisition of Meikang Biotech (China), a manufacturer of rapid tests
Acquisition of Shanghai Zenka Biotechnology (China), a specialist in culture media

 

2011

Acquisition of AES Laboratoire (France), an industrial microbiology company
Acquisition of ARGENE
® (France), a specialist in molecular biology

 

2012

Acquisition of RAS (India),
a specialist in molecular biology

Show in media library: 
 

2014

Acquisition of BIOFIRE® Diagnostics Inc., a privately held US-based company specialized in molecular biology

BioFire Diagnostics Inc., a privately held U.S.-based company specialized in molecular biology - See more at: http://www.biomerieux.com/en/biomerieux-finalizes-acquisition-us-company...
BioFire Diagnostics Inc., a privately held U.S.-based company specialized in molecular biology - See more at: http://www.biomerieux.com/en/biomerieux-finalizes-acquisition-us-company...
 

2016

Acquisition of Applied Maths, a Belgian specialist in software solutions to manage complex biological data

 

2018

Acquisition of Astute Medical Inc., a US company dedicated to the diagnosis of high-risk acute medical conditions

 

 

bioMérieux’s commitment to public health and expertise in biology is also rooted in its unique family history. Find out more

Pioneering diagnostics